Biogen Experimental Drug Can Repair Optic Nerve Damage in MS Patients

January 8, 2015 3:26 PM

3
0

Biogen Idec announced on Thursday that its experimental drug is showing promising results that it can repair optic nerve damage.

The experimental drug called Anti-LINGO-1 is currently tested in patients with multiple sclerosis (MS), a chronic disease that affects the brain, spinal cord and the optic nerves in the eyes. Patients with this condition often suffer from problems in vision, balance, muscle control and other basic f...